1. Ajani JA, Van Cutsem E, Moiseyenko V et al (2003) Docetaxel (D), cisplatin, 5-fluorouracil compared to cisplatin (C) and 5-fluorouracil (F) for chemo-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): interim results of a randomized phase III trial (V325). Proc Am Soc Clin Oncol 22:abstr. 999
2. Al-Batran SE, Atmaca A, Hegewisch-Becker S et al (2004) Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol 22:658–663
3. Allum W, Cunningham D, Weeden S et al (2003) Preoperative chemotherapy in operable gastric and lower esophageal cancer: A randomized controlled trial (The MAGIC trial). Proc Am Soc Clin Oncol abstr. 998
4. Bouche O, Raoul JL, Giovanni M et al (2003) Randomized phase II trial of LV5FU2, LV5FU2-cisplatinum or LV5FU2-irinotecan in patients (pts) with metastatic gastric or cardial adenocarcinoma (MGA): final results of study FFCD 9803. Proc Am Soc Clin Oncol 22:abstr 1033
5. Caudry M (1992) Gastric cancer: Radiotherapy and approaches to locally unresectable or recurrent disease. In: Ahlgren JD, MacDonald JS (eds) Gastrointestinal Oncology. Lippincott, Philadelphia, pp 181–187